TRIB TRINITY BIOTECH PLC
Price Chart
Executive Summary
Trinity Biotech filed a 424B5 prospectus supplement to establish a new at-the-market (ATM) offering facility with Lucid Capital Markets for up to $4.35 million of ADSs. The filing comes just days after terminating a prior ATM with Craig-Hallum, highlighting the company's urgent need for working capital to support operations amid a deeply negative equity position (-$72M shareholders' equity as of Dec 31, 2025), heavy debt load ($132M total debt pro forma), and ongoing Nasdaq MVPHS delisting risk. The up-to-32% dilution from the max offering compounds the already massive potential dilution from existing convertible obligations and the Yorkville SEPA.
Actionable Insight
This ATM adds a new dilutive capital source but does not address the fundamental solvency risk. Monitor for actual ADS sale volumes and pricing disclosures on Form 6-K filings. The stock trades near $0.67 — any acceleration of ATM sales could further pressure price. The Perceptive conversion overhang (potentially 8.3x current shares) and Yorkville SEPA remain the dominant bearish structural factors.
Key Facts
- New ATM facility with Lucid Capital Markets for up to $4,352,314 in aggregate offering price of ADSs
- 3.0% commission to Lucid on gross proceeds; Lucid indemnified for securities law liabilities
- 635,571 new ADSs represent up to ~32% dilution vs. 20,250,869 ADSs outstanding pre-offering
- Shareholders' equity was negative $(71,982,000) as of Dec 31, 2025; accumulated deficit of $(116,169,000)
- Pro forma total debt of $132,121,000 including $115,581,000 Senior Secured Term Loan
- Up to 3.36 billion additional Ordinary Shares potentially issuable to Perceptive at minimum conversion price of $0.5061 per ADS
- Yorkville SEPA allows sale of up to $25M of ADSs at 95-97% of VWAP, adding further overhang
- Prior ATM with Craig-Hallum was terminated June 2, 2026 (had been inactive since March 2025)
- Proceeds to be used for general corporate purposes and working capital
- Cash and cash equivalents were only $5,138,000 actual / $7,638,000 pro forma as of Dec 31, 2025
Financial Impact
Up to $4.35M gross proceeds with net ~$4.22M after 3% commission; potential dilution of up to 32% of current ADS float at assumed price of $0.6642/ADS
Risk Factors
- Immediate and substantial dilution to existing shareholders upon any ATM sales
- Massive overhang from Perceptive conversion obligations (up to 3.36B shares) and Yorkville SEPA ($25M)
- Negative shareholders' equity and high debt load raise going-concern risk
- Nasdaq delisting risk from MVPHS non-compliance remains unresolved
- Cash position of only $5.1-7.6M against $132M debt suggests severe liquidity constraints
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001554855-26-001320 |
| Document: 0001554855-26-001320-index-headers.html | 0001554855-26-001320 |
| Document: 0001554855-26-001320-index.html | 0001554855-26-001320 |
| Document: 0001554855-26-001320.txt | 0001554855-26-001320 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
2d ago
|
6-K
| $0.6600 awaiting T+1 | awaiting T+1 | — | $0.6500 (+1.52%) |
|
Jun 12, 2026
2d ago
|
424B5
| $0.6600 awaiting T+1 | awaiting T+1 | — | $0.6500 (+1.52%) |
|
Jun 11, 2026
4d ago
|
EFFECT
| $0.6837 awaiting T+1 | awaiting T+1 | — | $0.6500 (+4.93%) |
|
Jun 3, 2026
11d ago
|
F-1/A
| $0.6800 $0.6700 | ▲ +1.47% | ▼ −1.13% | $0.6500 (+4.41%) |
|
May 26, 2026
20d ago
|
EFFECT
| $0.6500 $0.6800 | ▼ −4.62% | ▼ −4.60% | $0.6500 (+0.00%) |
|
Mar 23, 2026
11w ago
|
Press Release
| $0.6000 $0.6100 | ▲ +1.67% | ▲ +2.02% | $0.6500 (+8.33%) |
|
Mar 4, 2026
14w ago
|
EFFECT
| $0.7000 $0.7300 | ▲ +4.29% | ▲ +4.86% | $0.6500 (−7.14%) |
|
Feb 25, 2026
15w ago
|
F-1
| $0.7500 $0.7200 | ▲ +4.00% | ▲ +3.45% | $0.6500 (+13.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access